Providing personalized and therapy-adapted solutions for individuals dealing with obesity and undergoing stomach surgery.
BounceWatch is an independent company data service, not affiliated with Baricol Bariatrics. To contact Baricol Bariatrics, visit baricolbariatrics.se.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Baricol Bariatrics compare?
A PDF of Baricol Bariatrics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Baricol Bariatrics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Baricol Bariatrics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutBaricol Bariatrics is a biotechnology and healthcare startup founded in 2013 with the slogan "Providing personalized and therapy-adapted solutions for individuals dealing with obesity and undergoing stomach surgery." The company offers tailor-made and therapy-adapted products and services for patients dealing with obesity and undergoing stomach surgery.
The last investment of Baricol Bariatrics was a Seed Round investment in January 2014 by Almi Invest.
Business keywords: obesity treatment, bariatric surgery, personalized solutions, therapy-adapted products, therapy services, stomach surgery support, tailor-made solutions, weight management, surgical innovations
| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 1 |
|
01 Jan 2014 |
Designed by Nature, Delivered by Science: A new class of incretin therapy for diabetes, obesity and...
America’s premier weight-loss and metabolic health-solutions company.
Advancing a new class of oral gut-targeted polymeric drugs for the treatment of T2D and Obesity
Source: BounceWatch company record for Baricol Bariatrics, https://bouncewatch.com/company/baricol-bariatrics, updated 11 October 2024. When citing, please name BounceWatch and link this page.
Analytics cookies (ours + Google). We use analytics cookies (our own and Google Analytics) to understand how the site is used. Essential cookies are always on. You decide on analytics. Cookie Policy
